Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Decibel Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −10 vs. Q2 2021
- Shares held
- 18.9M
- −673.6K (−3.4%) vs. Q2 2021
- Total value
- $145.9M
- −$22.2M (−13.2%) vs. Q2 2021
- New holders
- 4
- 8 more added
- Sold out
- 14
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 44 | $0 | 0.00% | −2−4.3% | Reduced |
| Evoke Wealth, LLC | 100 | $0 | 0.00% | +100 | New |
| Optiver Holding B.V. | 867 | $7.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,075 | $16.0K | 0.00% | +269+14.9% | Added |
| Laurion Capital Management LP | 15,053 | $116.0K | 0.00% | −5,252−25.9% | Reduced |
| Federated Hermes, Inc. | 15,000 | $116.0K | 0.00% | +5,000+50.0% | Added |
| Northern Trust Corp | 15,239 | $117.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 15,700 | $121.0K | 0.00% | +15,700 | New |
| Bank of America Corp | 19,273 | $148.0K | 0.00% | +18,081+1,516.9% | Added |
| Ergoteles LLC | 19,968 | $154.0K | 0.01% | +19,968 | New |
| Susquehanna International Group, LLP | 22,426 | $173.0K | 0.00% | +22,426 | New |
| Bank of New York Mellon Corp | 27,310 | $211.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 28,154 | $217.0K | 0.00% | −47,233−62.7% | Reduced |
| AlphaCentric Advisors LLC | 37,500 | $289.0K | 0.07% | −7,500−16.7% | Reduced |
| Millennium Management LLC | 38,536 | $297.0K | 0.00% | −31,381−44.9% | Reduced |
| Atlas Capital Advisors LLC | 41,025 | $316.3K | 0.05% | +23,227+130.5% | Added |
| Neuberger Berman Group LLC | 43,535 | $336.0K | 0.00% | +185+0.4% | Added |
| Geode Capital Management, LLC | 69,556 | $536.0K | 0.00% | −2,292−3.2% | Reduced |
| Bridgeway Capital Management, LLC | 114,928 | $886.0K | 0.02% | +42,928+59.6% | Added |
| Bronte Capital Management Pty Ltd. | 159,462 | $1.23M | 0.18% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 165,369 | $1.27M | 0.00% | −51,353−23.7% | Reduced |
| FMR LLC | 213,800 | $1.65M | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 251,950 | $1.94M | 0.00% | −1,901−0.7% | Reduced |
| Suvretta Capital Management, LLC | 263,600 | $2.03M | 0.03% | 00.0% | Unchanged |
| Woodline Partners LP | 280,473 | $2.16M | 0.04% | −380.0% | Reduced |
| Foresite Capital Management IV, LLC | 297,711 | $2.29M | 0.34% | 00.0% | Unchanged |
| Harvard Management Co Inc | 328,798 | $2.54M | 0.15% | 00.0% | Unchanged |
| Bessemer Group Inc | 494,071 | $3.81M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 625,215 | $4.82M | 0.00% | +253,441+68.2% | Added |
| Samsara BioCapital, LLC | 826,422 | $6.37M | 1.06% | 00.0% | Unchanged |
| Casdin Capital, LLC | 1,170,048 | $9.02M | 0.23% | −1,373−0.1% | Reduced |
| Alphabet Inc. | 1,636,258 | $12.6M | 0.30% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,777,659 | $13.7M | 0.02% | +3,828+0.2% | Added |
| BlackRock Inc. | 1,821,550 | $14.0M | 0.00% | −2,760−0.2% | Reduced |
| TRV GP III, LLC | 3,139,685 | $24.2M | 4.60% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,945,192 | $38.1M | 0.42% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −682,597−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −43,400−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −34,001−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −27,047−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −15,900−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −13,594−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −12,821−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,742−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −514−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −52−100.0% | Sold out |